Laboratory control of oral anticoagulants.
作者信息
Poller L
出版信息
Br Med J (Clin Res Ed). 1987 May 9;294(6581):1184. doi: 10.1136/bmj.294.6581.1184.
Abstract
摘要
相似文献
1
Laboratory control of oral anticoagulants.口服抗凝剂的实验室监测
Br Med J (Clin Res Ed). 1987 May 9;294(6581):1184. doi: 10.1136/bmj.294.6581.1184.
2
Questions and answers on prothrombin time standardisation in oral anticoagulant control.口服抗凝治疗中凝血酶原时间标准化的问答
Thromb Haemost. 1985 Aug 30;54(2):515-7.
3
Thromboplastin and oral anticoagulant control.凝血活酶与口服抗凝剂控制
Br J Haematol. 1987 May;66(1):1-4.
4
Control of oral anticoagulants by the prothrombin time: a plea for uniformity.通过凝血酶原时间控制口服抗凝剂：呼吁统一标准。
Med J Aust. 1978 Nov 4;2(10):459-61. doi: 10.5694/j.1326-5377.1978.tb131641.x.
5
Thromboplastin and oral anticoagulant control.凝血活酶与口服抗凝剂控制
Br J Haematol. 1987 Sep;67(1):116-7. doi: 10.1111/j.1365-2141.1987.tb02307.x.
6
ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.国际血液学标准化委员会/国际血栓与止血学会关于口服抗凝治疗中凝血酶原时间报告的建议。
Acta Haematol. 1984;72(6):405-7. doi: 10.1159/000206427.
7
Control of oral anticoagulant treatment.口服抗凝治疗的控制
Br Med J. 1971 Nov 6;4(5783):317-8.
8
International normalized ratio in the control of oral anticoagulant therapy.口服抗凝治疗控制中的国际标准化比值
Br J Haematol. 1995 Mar;89(3):683-4. doi: 10.1111/j.1365-2141.1995.tb08392.x.
9
ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.国际血液学标准化委员会/国际血栓与止血学会关于口服抗凝治疗中凝血酶原时间报告的建议。
Clin Chim Acta. 1985 Mar 15;146(2-3):229H-233H.
10
Control of anticoagulant treatment.抗凝治疗的控制
Lancet. 1969 Nov 8;2(7628):990-1.
引用本文的文献
1
Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.口服抗凝治疗：抗血栓治疗和血栓预防，第 9 版：美国胸科医师学会基于证据的临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e44S-e88S. doi: 10.1378/chest.11-2292.
2
Laparoscopic cholecystectomy in patients undergoing anticoagulant therapy.接受抗凝治疗患者的腹腔镜胆囊切除术
Surg Today. 1998;28(3):308-12. doi: 10.1007/s005950050128.
3
Hemostatic complications in renal disorders of the young.青少年肾脏疾病中的止血并发症。
Pediatr Nephrol. 1996 Feb;10(1):88-99. doi: 10.1007/BF00863459.
4
Effect of the choice of WHO International Reference Preparation for thromboplastin on International Normalised Ratios.凝血活酶的世界卫生组织国际参考制剂的选择对国际标准化比值的影响。
J Clin Pathol. 1993 Jan;46(1):64-6. doi: 10.1136/jcp.46.1.64.
5
Acute gastrointestinal haemorrhage in anticoagulated patients: diagnoses and response to endoscopic treatment.抗凝治疗患者的急性胃肠道出血：诊断及内镜治疗反应
Gut. 1994 Apr;35(4):464-6. doi: 10.1136/gut.35.4.464.
6
Anticoagulants in venous thromboembolism.静脉血栓栓塞中的抗凝剂。
BMJ. 1988 Nov 19;297(6659):1285-8. doi: 10.1136/bmj.297.6659.1285.
7
Control of warfarin therapy.华法林治疗的控制
Postgrad Med J. 1989 Sep;65(767):611-2. doi: 10.1136/pgmj.65.767.611.
8
A simple technique for predicting maintenance dosage of warfarin--is it better than empirical dosing?一种预测华法林维持剂量的简单技术——它比经验性给药更好吗？
Eur J Clin Pharmacol. 1989;37(6):573-6. doi: 10.1007/BF00562547.
本文引用的文献
1
Dosage and control of oral anticoagulants: an international collaborative survey.
Br J Haematol. 1982 Jul;51(3):479-85. doi: 10.1111/j.1365-2141.1982.tb02805.x.
2
A collaborative calibration study of reference materials for thromboplastins.
Thromb Haemost. 1983 Oct 31;50(3):712-7.
3
4
Calibration of BCT/441, the ICSH reference preparation for thromboplastin.
Thromb Haemost. 1986 Jun 30;55(3):379-82.
Zotero 插件